Phase I/II Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA
Phase of Trial: Phase I/II
Latest Information Update: 07 Mar 2018
At a glance
- Drugs ABO 102 (Primary)
- Indications Mucopolysaccharidosis III
- Focus Adverse reactions; First in man
- Sponsors Abeona therapeutics
- 08 Feb 2018 According to an Abeona Therapeutics media release, results from this study were presented at the WORLDSymposium for Lysosomal Diseases meeting.
- 08 Feb 2018 Results published in the Abeona therapeutics Media Release.
- 02 Feb 2018 According to an Abeona Therapeutics media release, data will be presented at the 14th Annual WORLDSymposium meeting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History